Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

p21 Antikörper

Dieses Anti-p21-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von p21 in WB, IHC, ELISA, IF, IP, MA und FM. Geeignet für Human. Dieses Primary Antibody wurde in 6+ Publikationen zitiert.
Rockland
Produktnummer ABIN105216
Hersteller Produkt- Nr.: 200-301-171

Kurzübersicht für p21 Antikörper (ABIN105216)

Target

Alle p21 (CDKN1A) Antikörper anzeigen
p21 (CDKN1A) (Cyclin-Dependent Kinase Inhibitor 1A (p21, Cip1) (CDKN1A))

Reaktivität

  • 289
  • 125
  • 102
  • 36
  • 14
  • 12
  • 6
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 240
  • 76
  • 1
Maus

Klonalität

  • 207
  • 109
  • 1
Monoklonal

Konjugat

  • 124
  • 21
  • 15
  • 15
  • 10
  • 9
  • 8
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
Dieser p21 Antikörper ist unkonjugiert

Applikation

  • 192
  • 99
  • 97
  • 67
  • 66
  • 66
  • 66
  • 41
  • 41
  • 35
  • 33
  • 22
  • 19
  • 19
  • 5
  • 2
  • 2
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF), Immunoprecipitation (IP), Multiplex Assay (MA), Fluorescence Microscopy (FM)

Klon

WA-1
  • Hersteller Produkt- Nr.

    200-301-171

    Hersteller

    Rockland

    Verwendungszweck

    p21 WAF1 Antibody

    Kreuzreaktivität (Details)

    This protein A purified mouse monoclonal antibody reacts with human and mammalian p21. The intracellular protein p21 is a 21 kD protein and also known as wild-type p53-activated fragment 1 (WAF1).

    Produktmerkmale

    Synonyms: mouse anti-p21/WAF1 antibody, Cyclin-dependent kinase inhibitor 1A (p21, CIP1) antibody, DNA Synthesis Inhibitor antibody, MDA 6 antibody, MDA6 antibody, Melanoma Differentiation Associated Protein 6 antibody

    Aufreinigung

    Protein A purified

    Sterilität

    Sterile filtered

    Immunogen

    Immunogen: This protein A purified monoclonal antibody was produced by repeated immunizations with recombinant human p21 fusion protein.

    Immunogen Type: Recombinant Protein

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Immunohistochemistry Dilution: User Optimized

    Application Note: Anti-p21/WAF1 has been tested in ELISA, western blot, and immunofluorescence. This product is also suitable for immunohistochemistry. The antibody detects a 21 kDa band corresponding to the p21 protein.  MCF7 cells or UV treated fibroblasts are suggested as a positive control for immunoblotting and immunohistochemistry.   Methanol/acetone fixed tissue is reactive for immunohistochemistry. The antibody also reacts with breast carcinoma on frozen sections (methanol/acetone fixation) and on paraffin sections (formalin fixation and microwave treatment prior to staining).  In ELISA this monoclonal antibody is useful either as a capture antibody (attached to the solid phase) or for detection of p21 protein.  This antibody immunoprecipitates monomeric p21WAF1 and not p21 complexes with other proteins. High level expression of p21WAF1 requires induction of wild-type p53 expression (e.g. via exposure to DNA damaging agents).

    Western Blot Dilution: 1:2,000 - 1:10,000

    Immunoprecipitation Dilution: 1:100

    ELISA Dilution: 1:5,000 - 1:20,000

    IF Microscopy Dilution: 1:250

    Other: User Optimized

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1.0 mg/mL

    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.5 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store vial at -20° C prior to opening.  Aliquot contents and freeze at -20° C or below for extended storage.  Avoid cycles of freezing and thawing.  Centrifuge product if not completely clear after standing at room temperature.  This product is stable for several weeks at 4° C as an undiluted liquid.  Dilute only prior to immediate use.

    Haltbarkeit

    12 months
  • Supiot, Hill, Bristow: "Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53." in: Molecular cancer therapeutics, Vol. 7, Issue 4, pp. 993-9, (2008) (PubMed).

    Joshi, Chen, Kalemkerian, Adil, Kraut, Sarkar: "Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer." in: Cancer gene therapy, Vol. 5, Issue 3, pp. 183-91, (1998) (PubMed).

    Kagawa, Fujiwara, Hizuta, Yasuda, Zhang, Roth, Tanaka: "p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells." in: Oncogene, Vol. 15, Issue 16, pp. 1903-9, (1997) (PubMed).

    Yang, Perkins, Ohno, Nabel, Nabel: "The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo." in: Nature medicine, Vol. 1, Issue 10, pp. 1052-6, (1996) (PubMed).

    Waldman, Kinzler, Vogelstein: "p21 is necessary for the p53-mediated G1 arrest in human cancer cells." in: Cancer research, Vol. 55, Issue 22, pp. 5187-90, (1995) (PubMed).

    Yeh, Shatkin: "A cis-acting element in Rous sarcoma virus long terminal repeat required for promoter repression by HeLa nuclear protein p21." in: The Journal of biological chemistry, Vol. 270, Issue 26, pp. 15815-20, (1995) (PubMed).

  • Target

    p21 (CDKN1A) (Cyclin-Dependent Kinase Inhibitor 1A (p21, Cip1) (CDKN1A))

    Andere Bezeichnung

    CDKN1A

    Hintergrund

    Background: p21WAF1 is a tumor suppressor gene product critical to maintain proper regulatory control of cell division. p21WAF1 inhibits cyclin/cyclin-dependent kinase (cdk) complexes, causing cell cycle arrest by blocking cell division at the S phase. Various mutations of tumor suppressor genes have been associated with different types of cancers. In these cases, somatic gene therapy with wild-type versions of tumor suppressor genes have been contemplated as anti-cancer therapeutic approaches. p21WAF1 contains p53-binding sites in its promoter and expression of p21WAF1 is induced in WI38 fibroblasts with PMA. Anti-p21WAF1 antibody is useful for researches interested in studying tongue and gastrointestinal cancers, as well as, ubiquitin and cyclin binding proteins.

    Gen-ID

    1026

    NCBI Accession

    NP_510867

    UniProt

    P38936

    Pathways

    p53 Signalweg, PI3K-Akt Signalweg, Zellzyklus, AMPK Signaling, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Mitotic G1-G1/S Phases, DNA Replication, Hepatitis C, Synthesis of DNA, Autophagie
Sie sind hier:
Chat with us!